Hanghang Wu

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potential.

Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potential.

Journal: Gut
Published: July 09, 2024

Identification of PRMT5 as a therapeutic target in cholangiocarcinoma.

Identification of PRMT5 as a therapeutic target in cholangiocarcinoma.

Journal: Gut
Published: May 31, 2024

Fecal microbiota transplantation from female donors restores gut permeability and reduces liver injury and inflammation in middle-aged male mice exposed to alcohol.

Fecal microbiota transplantation from female donors restores gut permeability and reduces liver injury and inflammation in middle-aged male mice exposed to alcohol.

Journal: Frontiers in nutrition
Published: February 28, 2024

Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury.

Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury.

Journal: Redox biology
Published: January 19, 2024

A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of Ppp2r5d.

A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of Ppp2r5d.

Journal: Cancers
Published: July 14, 2023

Application of cardiovascular interventions to decrease blood loss during hepatectomy: a systematic review and meta-analysis.

Application of cardiovascular interventions to decrease blood loss during hepatectomy: a systematic review and meta-analysis.

Journal: BMC anesthesiology
Published: November 07, 2022

JNKs protect from cholestatic liver disease progression by modulating Apelin signalling.

JNKs protect from cholestatic liver disease progression by modulating Apelin signalling.

Journal: JHEP reports : innovation in hepatology
Published: September 22, 2022

Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease.

Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease.

Journal: Cancers
Published: December 02, 2021

Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy.

Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy.

Journal: Cell death & disease
Published: July 05, 2021

Fibrotic Events in the Progression of Cholestatic Liver Disease.

Fibrotic Events in the Progression of Cholestatic Liver Disease.

Journal: Cells
Published: April 13, 2021
Showing 1-10 of 10

Last Updated: 09/26/2026